Roche

(IN BRIEF) Basilea Pharmaceutica has partnered with INCATE, the European incubator for antibacterial therapies, to support the advancement of early-stage anti-infective innovations. As an industry partner, Basilea brings deep expertise in antibacterial and antifungal drug development, while expanding INCATE’s scope … Read the full press release →

(IN BRIEF) Nokia has appointed Kristen Pressner as Chief People Officer and member of the Group Leadership Team, effective May 2026. With over 30 years of HR and leadership experience at Roche and Texas Instruments, Pressner will lead Nokia’s global … Read the full press release →

(IN BRIEF) Roche announced that its Phase III INShore trial evaluating Gazyva/Gazyvaro (obinutuzumab) in children and young adults with idiopathic nephrotic syndrome met its primary endpoint, showing superior sustained remission rates at one year compared to mycophenolate mofetil (MMF). The … Read the full press release →